ENDPOINTS

Bourla says Pfizer could transfer production to US to sidestep Trump's tariffs

Pfizer could “quickly” transfer operations from foreign sites to its US manufacturing network as a way to mitigate any impact from President Donald Trump’s tariffs, CEO Albert Bourla said. The pharma company’s manufacturing arm Pfizer ...

Mar 4, 2025 - 12:44
 0
Bourla says Pfizer could transfer production to US to sidestep Trump's tariffs
Pfizer could “quickly” transfer operations from foreign sites to its US manufacturing network as a way to mitigate any impact from President Donald Trump’s tariffs, CEO Albert Bourla said. The pharma company’s manufacturing arm Pfizer ...
Read More

Tags:

Previous Article

Daily briefing: What another round of layoffs means for US science

Next Article

‘Stranger Things VR’ Studio’s Next Project ‘Face Jumping’ Looks Like Another Pat...

Related Posts

Travere plans to seek expanded label for kidney drug

Travere plans to seek expanded label for kidney drug

Feb 11, 2025  0

AstraZeneca’s SERD hits primary endpoint in late-stage trial, but first-line potential remains uncertain

AstraZeneca’s SERD hits primary endpoint in late-stage ...

Feb 26, 2025  0

HHS’ vaccine injury panel in limbo after monthlong meeting delay

HHS’ vaccine injury panel in limbo after monthlong meet...

Feb 27, 2025  0